4578 N Stock Overview
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Otsuka Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥958.25 |
| 52 Week High | JP¥1,247.81 |
| 52 Week Low | JP¥761.11 |
| Beta | 0.19 |
| 1 Month Change | -15.97% |
| 3 Month Change | -19.41% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 25.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4578 N | MX Pharmaceuticals | MX Market | |
|---|---|---|---|
| 7D | -16.0% | -1.9% | -0.4% |
| 1Y | n/a | -20.3% | -8.7% |
Return vs Industry: Insufficient data to determine how 4578 N performed against the MX Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 4578 N performed against the MX Market.
Price Volatility
| 4578 N volatility | |
|---|---|
| 4578 N Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in MX Market | 6.8% |
| 10% least volatile stocks in MX Market | 2.7% |
Stable Share Price: 4578 N's share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine 4578 N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1921 | 34,388 | Makoto Inoue | www.otsuka.com |
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, and insecticide and toiletry products.
Otsuka Holdings Co., Ltd. Fundamentals Summary
| 4578 N fundamental statistics | |
|---|---|
| Market cap | Mex$529.25b |
| Earnings (TTM) | Mex$47.00b |
| Revenue (TTM) | Mex$319.13b |
11.3x
P/E Ratio1.7x
P/S RatioIs 4578 N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4578 N income statement (TTM) | |
|---|---|
| Revenue | JP¥2.33t |
| Cost of Revenue | JP¥660.43b |
| Gross Profit | JP¥1.67t |
| Other Expenses | JP¥1.33t |
| Earnings | JP¥343.12b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Apr 30, 2025
| Earnings per share (EPS) | 638.85 |
| Gross Margin | 71.65% |
| Net Profit Margin | 14.73% |
| Debt/Equity Ratio | 3.4% |
How did 4578 N perform over the long term?
See historical performance and comparisonDividends
1.7%
Current Dividend Yield19%
Payout RatioDoes 4578 N pay a reliable dividends?
See 4578 N dividend history and benchmarks| Otsuka Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Mar 31 2025 |
| Days until Ex dividend | 58 days |
| Days until Dividend pay date | 36 days |
Does 4578 N pay a reliable dividends?
See 4578 N dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/22 10:32 |
| End of Day Share Price | 2025/02/19 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Otsuka Holdings Co., Ltd. is covered by 18 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Atsushi Seki | Barclays |
| Koichi Mamegano | BofA Global Research |
| Hidemaru Yamaguchi | Citigroup Inc |